Drug-drug interactions (DDIs) among widely and chronically prescribed medications are a
relevant health issue in clinical practice. Reported incidences in outpatients range from …

Drug interactions commonly occur in patients receiving treatment with multiple medications.
Most interactions remain unrecognized because drugs, in general, have a wide margin of …

A n D GUID eLIneS affordability may often dictate which medications may be prescribed.
Patients who have exhausted prescription drug coverage or who are uninsured may require …

The statins are widely used worldwide to reduce risk for cardiovascular events in both the
primary and secondary prevention settings. Although generally quite safe, the statins can be …

Significant drug interactions contribute to hospitalizations, mortality, and health care costs.
They often are preventable with a basic understanding of pharmacokinetics and …

Cholesterol-lowering drugs such as HMG-CoA reductase inhibitors (" statins") are
increasingly used in hypercholesterolemic patients who suffer from multiple concomitant …

Introduction: Statin monotherapy is generally well tolerated, with a low frequency of adverse
events. The most important adverse effects associated with statins are myopathy and an …

Statins are one of the most well-studied class of drugs and the benefits of statins in the
treatment and prevention of both cardiovascular and cerebrovascular disease are well …

3-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase inhibitors (the so-called statins:
atorvastatin, fluvastatin, pravastatin, lovastatin, rosuvastatin and simvastatin) are a well …

[Prevalence of potential drug-drug interactions in ambulatory patients with statin therapy]. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …